SN.L

Smith & Nephew plc | Cotação de Ações

Última atualização31/01/2025, 13:48:25

Preço£ 1.032,00

Variação (dia)-£ 0,50 (-0.05%)▼

Min. 52 Semanas£ 911,00

Máx. 52 Semanas£ 1.245,26

Capitalização de mercado--

Endereço: Building 5, Watford, WD18 8YE

Telefone: 44 1923 477 100

Funcionários: 18.000

SMITH & NEPHEW PLC ORD USD0.20SN.L

£ 1.032,00

- 0,50,048%

31/01/2025 13:48:25

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atual£ 1.032,00

Valor de mercado--

Abertura£ 1.004,50

Preço máximo£ 1.037,50

Preço mínimo£ 1.027,00

Volume£ 1,3 mi

Fechamento anterior£ 1.032,50

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Ações relacionadas

RELX PLC

REL.L ▲14.00% | £ 3.631,00

Smiths Group plc

SMIN.L ▼8.00% | £ 1.719,00

WPP plc

WPP.L ▼3.00% | £ 828,20

The Sage Group plc

SGE.L ▼1.50% | £ 1.291,00

Compass Group PLC

CPG.L ▲10.00% | £ 2.655,00

Busque ativos específicos e obtenha informações detalhadas sobre suas cotações

Utilize a função de busca para encontrar informações detalhadas sobre ativos específicos. Oferecemos dados precisos e atualizados, permitindo que você tome decisões informadas com base nas informações mais recentes do mercado.

Saiba mais sobre a brapi e nossa missão de fornecer informações confiáveis

Entenda a missão da brapi em fornecer informações estritamente informativas de fontes confiáveis. Valorizamos a transparência e a responsabilidade, incentivando investidores a buscar aconselhamento financeiro independente para decisões informadas.

Fique por dentro das últimas notícias do mundo financeiro em nosso Blog

Mantenha-se atualizado com as últimas notícias financeiras em nosso Blog. Publicamos artigos informativos e análises de especialistas para fornecer insights valiosos sobre o cenário financeiro em constante evolução.